Share this article and save a life!
The biggest healthcare supply chain innovation just dropped, and nobody’s talking about it.
Medline just became the first healthcare company to deploy AI robots that think, pick, and pack like humans.
On April 16, they partnered with Symbotic to revolutionize how medical supplies reach your hospital.
Think about this:
• Autonomous robots that know exactly what your OR needs before you do
• AI that maps every item to your hospital’s specific layout
• Zero human error in critical supply fulfillment
Why does this matter? 🎯
Remember the PPE crisis? The formula shortages? The IV fluid disasters?
Those weren’t just pandemic problems. They exposed a supply chain running on 1990s technology while treating 2026 patients.
Medline operates 45 distribution centers. They’re starting with one pilot in 2027.
But here’s what’s revolutionary: The AI doesn’t just move boxes. It learns consumption patterns, predicts demand spikes, and adapts to each hospital’s unique workflow.
Imagine your supply room knowing you’ll need extra surgical kits before your scheduler does.
This isn’t about replacing workers. It’s about ensuring that nurse hunting for gauze at 3 AM finds it instantly. That surgeon never runs out of the specific suture they prefer. That rural clinic gets the same speed and accuracy as downtown medical centers.
The healthcare industry spends $400 billion annually on supplies. We lose 25% to waste, expiration, and inefficiency.
Medline and Symbotic just declared war on that waste.
While everyone’s obsessed with clinical AI, the real revolution might be happening in the warehouse.
Because you can have the world’s best AI diagnostics, but if you can’t get basic supplies reliably, what’s the point?
♻️ Repost if healthcare supply chains need AI more than diagnostics
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
